Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines? F Khademi, RA Taheri, AY Avarvand, H Vaez, AA Momtazi-Borojeni, ... Microbial pathogenesis 121, 218-223, 2018 | 63 | 2018 |
Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost? F Khademi, M Derakhshan, A Yousefi-Avarvand, M Tafaghodi, ... Expert review of vaccines 17 (1), 31-44, 2018 | 56 | 2018 |
The frequency of exotoxin A and exoenzymes S and U genes among clinical isolates of Pseudomonas aeruginosa in Shiraz, Iran A Yousefi-Avarvand, R Khashei, HS Ebrahim-Saraie, A Emami, ... International journal of molecular and cellular medicine 4 (3), 167, 2015 | 53 | 2015 |
Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review F Khademi, M Derakhshan, A Yousefi-Avarvand, M Tafaghodi Iranian journal of basic medical sciences 21 (2), 116, 2018 | 32 | 2018 |
Antibiotic Resistance of Helicobacter pylori in Iranian Children: A Systematic Review and Meta-Analysis A Yousefi-Avarvand, H Vaez, M Tafaghodi, AH Sahebkar, M Arzanlou, ... Microbial Drug Resistance 24 (7), 980-986, 2018 | 29 | 2018 |
A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA: DDA hybrid nanoparticles stimulates mucosal and systemic immunity F Khademi, M Derakhshan, A Yousefi-Avarvand, A Najafi, M Tafaghodi Microbial pathogenesis 125, 507-513, 2018 | 26 | 2018 |
Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East SMS Pezeshki, N Saki, MV Ghandali, A Ekrami, AY Avarvand Blood research 56 (1), 38-43, 2021 | 20 | 2021 |
Prevalence of antibiotic resistance of Haemophilus Influenzae in Iran-a meta-analysis H Vaez, A Sahebkar, F Pourfarzi, A Yousefi-Avarvand, F Khademi Iranian journal of otorhinolaryngology 31 (107), 349, 2019 | 19 | 2019 |
HspX protein as a candidate vaccine against Mycobacterium tuberculosis: an overview A Yousefi-Avarvand, M Tafaghodi, S Soleimanpour, F Khademi Frontiers in Biology 13, 293-296, 2018 | 19 | 2018 |
Mycobacterium tuberculosis HspX/EsxS fusion protein: gene cloning, protein expression, and purification in Escherichia coli F Khademi, A Yousefi-Avarvand, M Derakhshan, Z Meshkat, M Tafaghodi, ... Reports of Biochemistry & Molecular Biology 6 (1), 15, 2017 | 17 | 2017 |
Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA: DDA hybrid nanoparticles and MPLA: Subcutaneous administration F Khademi, A Yousefi, M Derakhshan, A Najafi, M Tafaghodi Iranian Journal of Basic Medical Sciences 22 (8), 893, 2019 | 15 | 2019 |
Assessing the Potential Biological Activities of Postbiotics Derived from Saccharomyces cerevisiae: An In Vitro Study H Hosseini, A Abbasi, S Sabahi, S Akrami, A Yousefi-Avarvand Probiotics and Antimicrobial Proteins, 1-17, 2023 | 11 | 2023 |
Middle east Mycobacterium tuberculosis antibiotic resistance: a systematic review and meta-analysis F Khademi, A Yousefi-Avarvand, M Derakhshan, H Vaez, R Sadeghi Infection Epidemiology and Microbiology 3 (1), 25-35, 2017 | 10 | 2017 |
Bacterial etiology and antibiotic susceptibility pattern of female patients with urinary tract infection referred to Imam Khomeini Hospital, Ahvaz, Iran, 2019 S Akrami, R Abouali, MM Olapour, RHL Abady, H Yazdaninejad, ... Journal of Current Biomedical Reports 1 (1), 23-6, 2020 | 9 | 2020 |
Evaluating inhibitory effects of paclitaxel and vitamin D3 loaded poly lactic glycolic acid co-delivery nanoparticles on the breast cancer cell line S Khodaverdi, A Jafari, F Movahedzadeh, F Madani, AY Avarvand, ... Advanced Pharmaceutical Bulletin 10 (1), 30, 2020 | 9 | 2020 |
Formulation and optimization of a new cationic lipid-modified PLGA nanoparticle as delivery system for Mycobacterium tuberculosis HspX/EsxS fusion protein: an experimental design F Khademi, A Yousefi-Avarvand, M Derakhshan, MR Abbaspour, K Sadri, ... Iranian Journal of Pharmaceutical Research: IJPR 18 (1), 446, 2019 | 9 | 2019 |
Drug resistance of clinical and environmental isolates of Brucella species in Iran: a meta-analysis F Khademi, A Yousefi-Avarvand, A Sahebkar, B Mohammadi-Ghalehbin, ... Reviews and Research in Medical Microbiology 29 (4), 166-172, 2018 | 9 | 2018 |
Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model AY Avarvand, Z Meshkat, F Khademi, M Tafaghodi Microbial Pathogenesis 154, 104842, 2021 | 8 | 2021 |
The roles of latency-associated antigens in tuberculosis vaccines ZM Arshid Yousefi Avarvand, Farzad Khadem,Mohsen Tafaghodi, Zahra Ahmadipour ... Indian journal of tuberculosis, 2019 | 7 | 2019 |
A systematic review and meta-analysis on the epidemiology of antibiotic resistance of Vibrio cholerae in Iran. A Yousefi, H Vaez, A Sahebkar, F Khademi Annali di Igiene, Medicina Preventiva e di Comunità 31 (4), 2019 | 6 | 2019 |